Us Bancorp \De\ Mesoblast LTD Transaction History

Us Bancorp \De\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.94 - $4.18 $3,686 - $5,241	1,254 New	1,254 $4,000
Q1 2022 May 11, 2022	SELL	$3.58 - $4.98 $6,551 - $9,113	-1,830 Reduced 76.38%	566 $2,000
Q4 2021 Feb 11, 2022	BUY	$4.17 - $7.09 $5,191 - $8,827	1,245 Added 108.17%	2,396 $12,000
Q2 2021 Aug 05, 2021	SELL	$6.69 - $9.0 $3,164 - $4,257	-473 Reduced 29.13%	1,151 $8,000
Q1 2021 Apr 28, 2021	SELL	$8.26 - $11.4 $2,081 - $2,872	-252 Reduced 13.43%	1,624 $13,000
Q4 2020 Feb 04, 2021	BUY	$8.21 - $18.59 $2,068 - $4,684	252 Added 15.52%	1,876 $16,000
Q2 2020 Aug 07, 2020	BUY	$4.2 - $15.45 $1,272 - $4,681	303 Added 22.94%	1,624 $19,000
Q1 2020 May 13, 2020	BUY	$3.38 - $10.63 $4,464 - $14,042	1,321 New	1,321 $6,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.